ramucirumab,pembrolizumab
eli lilly,merck
['lcsm,(-blcsm)', 's1800a', 'lung', 'sclc', 'nsclc', 'ramucirumab', '9004', 'pembrolizumab']
happening now:
abstract 9004: osl from a phase ii randomized study of ramucirumab pembrolizumab vs. soc for advanced #nsclc previously treated with #io: #lungmap s1800a. hall d1 #asco22 #lcsm 
@UconnIM | HemOnc @AUBMC_Official | @USEKofficial Alumni | @ASCO SM Editor @JCOGO_ASCO | VTP Award @ASH_Hematology | Views are my own FCOI: https://t.co/nLxBFc8CcY